Network Pharmacology-Based Study of the Underlying Mechanisms of Huangqi Sijunzi Decoction for Alzheimer's Disease

CONCLUSION: HQSJZD was found to have the potential to treat AD by targeting multiple AD-related targets. Formononetin and hederagenin in HQSJZD may regulate multiple signalling pathways through AChE, which might play a therapeutic role in AD.PMID:34650613 | PMC:PMC8510793 | DOI:10.1155/2021/6480381

Source: Evidence-based Complementary and Alternative Medicine - October 15, 2021 Category: Complementary Medicine Authors: Wei Zhang Mingti Lv Yating Shi Yonghui Mu Zhaoyang Yao Zhijun Yang Source Type: research